Follow The Filings

MXL MaxLinear

MaxLinear earnings company data as of 9:58 AM ET 10/23

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 22 Oct EPS 0.32 0.62 Beat +93.8%
Rev — $218.1M —

Insider trades

Open-market buys and sales by MXL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MXL insider trades
  • None no insider bought on the open market
  • $59.7M sold by 7 insiders outside a trading plan
  • $839K sold by 1 insider under 10b5-1 plans
  1. Kishore Seendripu CEO
    Sale
    $50.4M 591,454 shares at $85.27 100% of stake
    Traded Aug 14–17 Filed Aug 18
  2. Thomas E Pardun Director
    Sale
    $1.2M 11,000 shares at $105.00 17% of stake
    Traded May 26 Filed May 28
  3. Connie H. Kwong Corporate Controller & PAO
    Sale
    $3.4M 35,000 shares at $96.96 72% of stake
    Traded May 8 Filed May 8
  4. Ted L Tewksbury III Director
    Planned sale
    $839K 10,660 shares at $78.68 12% of stake
    Traded May 1–5 Filed May 5
  5. Carolyn Beaver Director
    Sale
    $462K 6,000 shares at $76.96 15% of stake
    Traded May 4 Filed May 5
  6. Daniel A Artusi Director
    Sale
    $826K 10,500 shares at $78.64 38% of stake
    Traded May 4 Filed May 5
  7. Albert J Moyer Director
    Sale
    $1.2M 15,741 shares at $78.00 18% of stake
    Traded May 4 Filed May 5
  8. Connie H. Kwong Corporate Controller & PAO
    Sale
    $239K 4,118 shares at $58.00 7.8% of stake
    Traded Apr 29 Filed Apr 30
  9. Connie H. Kwong Corporate Controller & PAO
    Sale
    $772K 15,050 shares at $51.29 22% of stake
    Traded Apr 27 Filed Apr 28
  10. Steven G Litchfield See remarks
    Sale
    $746K 44,929 shares at $16.61 12% of stake
    Traded Mar 4–6 Filed Mar 6
  11. Daniel A Artusi Director
    Sale
    $463K 29,802 shares at $15.54 71% of stake
    Traded Oct 29–30 Filed Oct 30, 2025

Also filed in the last 12 months, not counted as buying or selling: 12 option exercises, 10 share withholdings for taxes, and 6 stock grants.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
10-Q
8-K 1.01,2.02,2.03,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 4.01,9.01
8-K 5.02,5.07,9.01
DEFA14A
8-K 1.01,2.02,2.03,9.01
10-Q
DEF 14A
DEFA14A
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.